Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan M Roden

Showing results (381-390 of 593) with videos related to

Pageof 60
Sort By:
Blood|July 5, 2011
Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapyInna Y Gong, Rommel G Tirona, Ute I Schwarz, et al.
Medrxiv : the Preprint Server for Health Sciences|June 29, 2026
Prevalence and Clinical Impact of Pathogenic Variants in Cardiomyopathy Genes Among Individuals with Cardiac Conduction DisordersTemidayo A Abe, Favour E Markson, Quinn S Wells, et al.
Journal of Biomedical Informatics|December 14, 2020
A retrospective approach to evaluating potential adverse outcomes associated with delay of procedures for cardiovascular and cancer-related diagnoses in the context of COVID-19Neil S Zheng, Jeremy L Warner, Travis J Osterman, et al.
American Journal of Human Genetics|December 2, 2022
Genomic Medicine Year in Review: 2022Teri A Manolio, Jahnavi Narula, Carol J Bult, et al.
Circulation|August 10, 2011
Striking In vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitroHiroshi Watanabe, Tao Yang, Dina Myers Stroud, et al.
Nature Reviews. Cardiology|September 1, 2025
Creating an atlas of variant effects to resolve variants of uncertain significance and guide cardiovascular medicineAndrew M Glazer, Daniel R Tabet, Victoria N Parikh, et al.
Nature Communications|October 13, 2016
KCNE1 induces fenestration in the Kv7.1/KCNE1 channel complex that allows for highly specific pharmacological targetingEva Wrobel, Ina Rothenberg, Christoph Krisp, et al.
Annals of Internal Medicine|November 23, 2006
Pharmacogenomics: challenges and opportunitiesDan M Roden, Russ B Altman, Neal L Benowitz, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2025
Clonal Hematopoiesis of Indeterminate Potential After Radiation TherapyShelby A Crants, Sydney S Olson, Yajing Li, et al.
The Journal of Clinical Investigation|May 3, 2008
The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndromeNaomasa Makita, Elijah Behr, Wataru Shimizu, et al.
Pageof 60

Showing results (381-390 of 593) with videos related to

Sort By:
Pageof 60
Blood|July 5, 2011
Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapyInna Y Gong, Rommel G Tirona, Ute I Schwarz, et al.
Medrxiv : the Preprint Server for Health Sciences|June 29, 2026
Prevalence and Clinical Impact of Pathogenic Variants in Cardiomyopathy Genes Among Individuals with Cardiac Conduction DisordersTemidayo A Abe, Favour E Markson, Quinn S Wells, et al.
Journal of Biomedical Informatics|December 14, 2020
A retrospective approach to evaluating potential adverse outcomes associated with delay of procedures for cardiovascular and cancer-related diagnoses in the context of COVID-19Neil S Zheng, Jeremy L Warner, Travis J Osterman, et al.
American Journal of Human Genetics|December 2, 2022
Genomic Medicine Year in Review: 2022Teri A Manolio, Jahnavi Narula, Carol J Bult, et al.
Circulation|August 10, 2011
Striking In vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitroHiroshi Watanabe, Tao Yang, Dina Myers Stroud, et al.
Nature Reviews. Cardiology|September 1, 2025
Creating an atlas of variant effects to resolve variants of uncertain significance and guide cardiovascular medicineAndrew M Glazer, Daniel R Tabet, Victoria N Parikh, et al.
Nature Communications|October 13, 2016
KCNE1 induces fenestration in the Kv7.1/KCNE1 channel complex that allows for highly specific pharmacological targetingEva Wrobel, Ina Rothenberg, Christoph Krisp, et al.
Annals of Internal Medicine|November 23, 2006
Pharmacogenomics: challenges and opportunitiesDan M Roden, Russ B Altman, Neal L Benowitz, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2025
Clonal Hematopoiesis of Indeterminate Potential After Radiation TherapyShelby A Crants, Sydney S Olson, Yajing Li, et al.
The Journal of Clinical Investigation|May 3, 2008
The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndromeNaomasa Makita, Elijah Behr, Wataru Shimizu, et al.
Pageof 60